Pregled bibliografske jedinice broj: 1111009
Post-Translational Modifications That Drive Prostate Cancer Progression
Post-Translational Modifications That Drive Prostate Cancer Progression // Biomolecules, 11 (2021), 2; 247, 44 doi:10.3390/biom11020247 (međunarodna recenzija, pregledni rad, znanstveni)
CROSBI ID: 1111009 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Post-Translational Modifications That Drive Prostate
Cancer Progression
Autori
Samaržija, Ivana
Izvornik
Biomolecules (2218-273X) 11
(2021), 2;
247, 44
Vrsta, podvrsta i kategorija rada
Radovi u časopisima, pregledni rad, znanstveni
Ključne riječi
SUMOylation ; acetylation ; glycosylation ; lipidation ; phosphorylation ; post-translational modification ; prostate cancer ; ubiquitination
Sažetak
While a protein primary structure is determined by genetic code, its specific functional form is mostly achieved in a dynamic interplay that includes actions of many enzymes involved in post- translational modifications. This versatile repertoire is widely used by cells to direct their response to external stimuli, regulate transcription and protein localization and to keep proteostasis. Herein, post-translational modifications with evident potency to drive prostate cancer are explored. A comprehensive list of proteome-wide and single protein post- translational modifications and their involvement in phenotypic outcomes is presented. Specifically, the data on phosphorylation, glycosylation, ubiquitination, SUMOylation, acetylation, and lipidation in prostate cancer and the enzymes involved are collected. This type of knowledge is especially valuable in cases when cancer cells do not differ in the expression or mutational status of a protein, but its differential activity is regulated on the level of post-translational modifications. Since their driving roles in prostate cancer, post-translational modifications are widely studied in attempts to advance prostate cancer treatment. Current strategies that exploit the potential of post-translational modifications in prostate cancer therapy are presented.
Izvorni jezik
Engleski
Znanstvena područja
Biotehnologija u biomedicini (prirodno područje, biomedicina i zdravstvo, biotehničko područje)
Citiraj ovu publikaciju:
Časopis indeksira:
- Web of Science Core Collection (WoSCC)
- Science Citation Index Expanded (SCI-EXP)
- SCI-EXP, SSCI i/ili A&HCI
- Scopus
- MEDLINE